Transaction #24967 · Form 4 · 0001934884-26-000007
HEALTHEQUITY, INC. · Purchase · Common Stock
HEALTHEQUITY, INC. · Transacted October 15, 2026 · Filed October 19, 2026
What does this filing report?
An SEC Form 4 filing for HEALTHEQUITY, INC. records a purchase involving Common Stock on October 15, 2026. The reported quantity was 108. The filing date is October 19, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- HEALTHEQUITY, INC.
- Company CIK
- 0001428336
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 108
- Reported price
- 90.33
- Reference value
- 9,755.64
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 53,405
- Ownership description
- Not reported
- SEC acceptance time
- Oct 19, 2026, 5:30 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Rajasekar Sunil ↗
EVP Chief Prod & Strat Officer
CIK 0001934884
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Represents shares sold in a short sale.
- F2
- The transactions reported were executed in broker-managed discretionary accounts without the reporting person's knowledge. The reporting of these transactions was untimely because the reporting person did not become aware of the transactions at the time they occurred.
- F3
- The reporting person has voluntarily paid to the issuer a de minimis amount (approximately $1,650), which represent all "profits" pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended, that resulted from the transactions reported herein.
- F4
- Represents shares delivered to cover the previous short sale.
Remarks
The Power of Attorney given by Mr. Rajasekar was previously filed with the U.S. Securities and Exchange Commission on May 12, 2026 as an exhibit to a statement on Form 3 filed by Mr. Rajasekar with respect to HealthEquity, Inc. and is hereby incorporated by reference.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.